Search


	Podcast:		BioCentury This Week
	Episode:		Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
	Category:		Science & Medicine
	Duration:		00:27:26
	Publish Date:		2024-12-03 02:00:00
	Description:		President-elect Donald Trump’s pick to lead NIH, Jay Bhattacharya, has made his career attacking the leadership and rank-and-file staffers at the institutes, argues Washington Editor Steve Usdin on the latest BioCentury This Week podcast. Usdin and colleagues discuss how Bhattacharya, should he be nominated and approved by the Senate, could lead NIH and how that could affect the biopharma industry. The BioCentury team then discusses its analysis of abstracts released ahead of the American Society of Hematology (ASH) and Society for Immunotherapy of Cancer (SITC) annual conferences, highlighting methods for applying dual or bispecific CAR T cell designs to solid tumors. And they also analyze FDA approvals of products by biotech companies, noting that current trends show biotechs shedding their reliance on pharma to get drugs across the finish line for approval. View full story: https://www.biocentury.com/article/654363 00:00 - Introduction 01:08 - Trump's NIH Pick 12:13 - Multi-targeted CAR Ts 19:26 - Biotech FDA Approvals To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com. Reach us by sending a text
	Total Play:		0